Migliorare le linee guida del consenso informato

i-CONSENT, finanziato dal programma Horizon 2020 dell’Unione Europea, ha lo scopo di migliorare il modo in cui i pazienti ricevono le informazioni dagli studi clinici. All’interno del progetto, verranno create una serie di linee guida per migliorare il processo del consenso informato, includendo le popolazioni vulnerabili, da una prospettiva di gender e basandosi sulle tecnologie ICT.

Il Progetto

Project guidelines now available!

Mar 25, 2021

The i-CONSENT Project publishes its final product: "Guidelines for tailoring the informed consent process in clinical studies" Fragment of the guidelines. The i-CONSENT Guidelines are now ready and available for academia, clinical investigators, pharmaceutical...

leggi tutto
View All
Visit our Twitter and get the latest content!
@ICONSENTEU

i-CONSENTFollow

H2020 project aimed to improve #informedconsent by focusing on gender, age and vulnerable populations to promote patient autonomy and empowerment through TIC.

Avatar
Retweet on Twitteri-CONSENT Retweeted
AvatarÁrea de Investigación en Vacunas@AIVFisabio·
8 Set

#DíaMundialAlfabetización | Hoy queremos poner en valor una de las vertientes de este derecho: la alfabetización en #salud.

➡️Descubre los materiales que hemos creado con @ICONSENTEU con el objetivo de que la sociedad sea más independiente y sostenible

https://i-consentproject.eu/

Reply on Twitter 1435553292063477763Retweet on Twitter 14355532920634777631Like on Twitter 14355532920634777632Twitter 1435553292063477763
Load More...

i-CONSENT in Numbers

Dal 2017 al 2020

Partners

milioni di finanziamenti europei

paesi

Durata 3 anni

Multimedia

 i-CONSENT falls under the ‘Science with and for Society’ (SWAFS) programme, which means that on of our main goals is unlocking science for use by the wider public. i-CONSENT is committed to improving citizens’ health literacy not only as a solution to make science more attractive to them but also as a way of empowering them. This section will offer visitors and stakeholders information on the project, in particular, and  knowledge on clinical trials, research and ethics, in general.